data_2l5j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l5j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 122.729 1.252 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.484 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 49.8 t-80 -98.3 -68.21 0.81 Allowed 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.914 170.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 tpt -128.27 101.5 6.27 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.249 1.02 . . . . 0.0 108.485 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 145.76 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 125.022 2.344 . . . . 0.0 110.16 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.343 92.8 m-85 -56.36 -108.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 109.977 -3.283 . . . . 0.0 110.729 134.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -128.88 -121.81 0.23 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 110.361 -3.108 . . . . 0.0 107.932 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -90.91 -48.04 7.24 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.268 61.4 mmt-85 . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 127.1 3.334 . . . . 0.0 119.973 -164.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.261 24.3 pttm -127.07 75.15 76.82 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.303 25.3 Cg_endo -68.18 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.327 2.685 . . . . 0.0 109.407 150.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -43.52 -24.43 0.11 Allowed 'General case' 0 N--CA 1.511 2.61 1 N-CA-C 125.718 5.451 . . . . 0.0 125.718 147.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -59.49 1.06 0.51 Allowed Glycine 0 CA--C 1.551 2.339 1 CA-C-N 107.135 -4.575 . . . . 0.0 121.137 157.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -54.78 -49.44 70.91 Favored 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.5 85.28 6.48 Favored 'General case' 0 C--N 1.289 -2.026 1 CA-C-N 105.842 -5.163 . . . . 0.0 112.244 147.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.484 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 4.0 t80 -77.93 -32.13 51.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.313 0.1 OUTLIER -50.25 -50.5 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 121.119 3.748 . . . . 0.0 121.119 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.05 -60.8 3.09 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.041 -5.527 . . . . 0.0 114.29 160.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . 0.277 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 123.003 1.382 . . . . 0.0 111.966 -170.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 122.709 1.242 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -102.54 -72.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.794 -1.548 . . . . 0.0 109.059 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.52 91.15 2.35 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -87.27 147.52 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 124.981 2.324 . . . . 0.0 109.447 161.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.364 89.4 m-85 -55.64 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 110.103 -3.226 . . . . 0.0 111.366 140.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.1 m -140.12 -118.6 0.12 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 109.993 -3.276 . . . . 0.0 108.366 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.85 -51.98 5.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 127.069 3.319 . . . . 0.0 119.557 -163.722 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.07 75.7 40.15 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.287 17.5 Cg_endo -68.58 -122.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.725 2.284 . . . . 0.0 108.812 144.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -46.56 -24.54 0.55 Allowed 'General case' 0 N--CA 1.51 2.549 1 N-CA-C 125.421 5.341 . . . . 0.0 125.421 148.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -57.37 0.49 0.23 Allowed Glycine 0 CA--C 1.551 2.326 1 CA-C-N 107.53 -4.395 . . . . 0.0 121.167 160.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -50.34 17.7 Favored 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 120.537 3.532 . . . . 0.0 120.537 163.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.59 95.73 9.78 Favored 'General case' 0 C--N 1.294 -1.816 1 CA-C-N 105.598 -5.274 . . . . 0.0 111.748 148.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.12 -18.98 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.312 0.0 OUTLIER -52.33 -49.26 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 120.569 3.544 . . . . 0.0 120.569 175.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.95 -60.54 2.56 Favored 'General case' 0 C--N 1.292 -1.908 1 CA-C-N 105.744 -5.207 . . . . 0.0 113.929 157.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 124.418 2.056 . . . . 0.0 110.917 -165.177 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 pt . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 122.611 1.196 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -98.53 -71.33 0.69 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.7 171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.4 ttp -140.41 91.17 2.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.669 0.788 . . . . 0.0 108.928 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.09 148.79 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 124.475 2.083 . . . . 0.0 109.367 159.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 93.6 m-85 -59.69 -100.24 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 110.998 -2.819 . . . . 0.0 112.141 147.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -95.33 -168.25 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 108.896 -3.775 . . . . 0.0 113.079 -154.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -90.24 -56.04 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.302 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.197 0 CA-C-O 127.307 3.432 . . . . 0.0 118.934 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.156 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.5 80.32 6.03 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 118.733 1.266 . . . . 0.0 111.505 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.302 25.8 Cg_endo -68.61 -119.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.261 2.641 . . . . 0.0 108.966 148.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.415 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 9.2 ptm180 -38.36 -33.83 0.11 Allowed 'General case' 0 N--CA 1.507 2.399 1 N-CA-C 125.221 5.267 . . . . 0.0 125.221 149.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 0.12 0.49 Allowed Glycine 0 CA--C 1.55 2.269 1 CA-C-N 107.309 -4.496 . . . . 0.0 121.379 164.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.59 -50.29 60.46 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.59 91.61 4.1 Favored 'General case' 0 C--N 1.291 -1.966 1 CA-C-N 105.769 -5.196 . . . . 0.0 111.653 149.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -72.83 -21.28 60.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.301 0.0 OUTLIER -52.36 -49.57 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 120.374 3.472 . . . . 0.0 120.374 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.8 -60.66 3.0 Favored 'General case' 0 C--N 1.292 -1.929 1 CA-C-N 105.419 -5.355 . . . . 0.0 114.293 158.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 124.502 2.096 . . . . 0.0 110.474 -165.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.834 1.302 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.471 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 53.1 t-80 -96.95 -69.54 0.75 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.818 171.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.5 ttp -130.33 94.61 3.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.898 0.879 . . . . 0.0 108.789 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.72 145.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 124.745 2.212 . . . . 0.0 109.88 159.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.358 86.7 m-85 -57.53 -106.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 110.302 -3.136 . . . . 0.0 110.407 137.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.9 m -128.01 -125.75 0.22 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 110.053 -3.249 . . . . 0.0 107.872 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -91.23 -52.54 4.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.274 83.4 mtt180 . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 127.14 3.353 . . . . 0.0 120.039 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -123.24 73.66 49.36 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.3 27.0 Cg_endo -68.97 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.365 2.71 . . . . 0.0 109.546 150.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.01 -27.31 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.725 1 N-CA-C 125.524 5.379 . . . . 0.0 125.524 145.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -60.4 0.71 0.85 Allowed Glycine 0 CA--C 1.553 2.408 1 CA-C-N 107.398 -4.455 . . . . 0.0 121.384 160.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.98 -50.67 60.81 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.43 91.79 6.83 Favored 'General case' 0 C--N 1.29 -1.989 1 CA-C-N 105.687 -5.233 . . . . 0.0 111.994 148.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.3 t80 -83.27 -27.39 29.88 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.351 0.1 OUTLIER -48.64 -50.72 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 121.612 3.93 . . . . 0.0 121.612 -170.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -79.84 -60.89 2.17 Favored 'General case' 0 C--N 1.288 -2.075 1 CA-C-N 105.498 -5.319 . . . . 0.0 113.033 161.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 124.629 2.156 . . . . 0.0 111.915 -165.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.3 pt . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 122.53 1.157 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -104.94 -72.17 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.026 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 ttt -140.98 80.78 1.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.738 0.815 . . . . 0.0 109.181 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.76 142.04 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-O 124.921 2.296 . . . . 0.0 109.301 165.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.36 89.2 m-85 -81.18 -78.09 0.19 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 110.182 -3.19 . . . . 0.0 114.628 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.1 m -126.07 -144.29 0.31 Allowed 'General case' 0 C--N 1.288 -2.108 1 CA-C-N 105.438 -5.346 . . . . 0.0 110.9 157.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -90.61 -29.16 17.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.333 1.4 mpt_? . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 126.895 3.236 . . . . 0.0 118.96 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 117.451 1.74 . . . . 0.0 117.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.03 69.43 13.87 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 118.732 1.266 . . . . 0.0 113.719 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.289 18.3 Cg_endo -69.92 -122.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.56 1.824 0 C-N-CA 123.017 2.478 . . . . 0.0 108.668 146.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -39.39 -29.0 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.643 1 N-CA-C 125.725 5.454 . . . . 0.0 125.725 147.249 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -61.7 1.07 1.28 Allowed Glycine 0 CA--C 1.547 2.034 1 CA-C-N 106.954 -4.657 . . . . 0.0 121.638 165.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -43.8 -52.15 6.87 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 121.15 3.759 . . . . 0.0 121.15 171.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.29 104.44 15.92 Favored 'General case' 0 C--N 1.293 -1.87 1 CA-C-N 105.397 -5.365 . . . . 0.0 111.141 149.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -83.32 -15.22 50.89 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -55.03 -50.36 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 120.645 3.572 . . . . 0.0 120.645 -175.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -69.13 -60.62 2.23 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.743 -5.208 . . . . 0.0 113.362 156.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 124.494 2.093 . . . . 0.0 110.96 -161.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -84.78 -71.72 0.51 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.248 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.67 91.52 1.97 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -79.99 139.78 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 124.798 2.237 . . . . 0.0 109.339 161.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 88.4 m-85 -76.86 -79.63 0.11 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 110.561 -3.018 . . . . 0.0 114.177 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -146.3 -109.25 0.09 Allowed 'General case' 0 C--N 1.291 -1.944 1 CA-C-N 106.122 -5.035 . . . . 0.0 109.857 151.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.56 -60.28 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.309 18.4 mmt180 . . . . . 0 N--CA 1.502 2.175 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -168.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -123.2 67.45 34.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.284 13.9 Cg_endo -68.89 -122.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 122.982 2.455 . . . . 0.0 108.985 145.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 55.1 ptt85 -40.58 -30.51 0.12 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 125.186 5.254 . . . . 0.0 125.186 148.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.18 0.92 0.17 Allowed Glycine 0 CA--C 1.551 2.282 1 CA-C-N 107.233 -4.53 . . . . 0.0 121.535 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -40.36 -51.44 2.8 Favored 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 121.856 4.021 . . . . 0.0 121.856 169.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.96 105.86 16.28 Favored 'General case' 0 C--N 1.292 -1.896 1 CA-C-N 105.731 -5.213 . . . . 0.0 110.671 150.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -81.43 -16.01 53.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.324 0.1 OUTLIER -54.65 -50.21 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 N-CA-C 120.549 3.537 . . . . 0.0 120.549 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.73 -60.6 2.41 Favored 'General case' 0 C--N 1.289 -2.027 1 CA-C-N 105.221 -5.445 . . . . 0.0 113.503 159.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 124.492 2.091 . . . . 0.0 110.683 -167.52 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 122.367 1.08 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.539 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 66.1 t60 -87.75 -72.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.242 165.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.57 100.31 3.58 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -97.77 145.88 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-O 124.967 2.318 . . . . 0.0 109.885 159.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.355 93.8 m-85 -58.47 -105.91 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 109.851 -3.34 . . . . 0.0 111.411 139.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 t -86.6 170.71 11.6 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.83 -3.35 . . . . 0.0 112.95 -162.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -72.02 -49.34 37.76 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.303 9.2 mtp-105 . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 127.679 3.609 . . . . 0.0 120.677 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.89 76.65 14.55 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.302 26.7 Cg_endo -67.29 -119.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.4 2.733 . . . . 0.0 109.643 147.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.448 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -43.5 -26.23 0.2 Allowed 'General case' 0 N--CA 1.513 2.69 1 N-CA-C 125.147 5.24 . . . . 0.0 125.147 149.311 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -58.91 1.07 0.37 Allowed Glycine 0 CA--C 1.551 2.301 1 CA-C-N 107.29 -4.504 . . . . 0.0 121.002 157.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.79 -51.13 58.71 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.14 84.81 4.36 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.721 -5.218 . . . . 0.0 112.803 147.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.539 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 6.6 t80 -81.59 -23.59 37.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.304 0.1 OUTLIER -52.39 -50.09 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 173.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -58.74 -60.48 3.77 Favored 'General case' 0 C--N 1.293 -1.849 1 CA-C-N 105.278 -5.419 . . . . 0.0 114.674 158.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 122.713 1.244 . . . . 0.0 110.325 -166.415 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 122.697 1.237 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.471 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 80.3 t60 -94.89 -73.72 0.57 Allowed 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.767 168.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -141.91 87.97 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.833 0.853 . . . . 0.0 109.022 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.7 m -76.66 146.5 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 125.462 2.553 . . . . 0.0 110.961 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.327 74.6 m-85 -53.96 -111.57 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.092 139.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -118.6 -140.06 0.35 Allowed 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 110.87 -2.877 . . . . 0.0 108.886 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.73 -53.73 4.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.73 -1.231 . . . . 0.0 112.982 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.306 56.0 mtt180 . . . . . 0 N--CA 1.501 2.12 0 CA-C-O 127.298 3.428 . . . . 0.0 120.098 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.255 60.8 pttt -119.99 72.28 17.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.303 23.9 Cg_endo -69.14 -119.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 123.411 2.74 . . . . 0.0 109.456 148.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -42.99 -25.31 0.09 Allowed 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 125.422 5.341 . . . . 0.0 125.422 147.378 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.58 1.15 1.19 Allowed Glycine 0 CA--C 1.552 2.401 1 CA-C-N 107.306 -4.497 . . . . 0.0 120.959 158.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -52.13 -50.89 60.83 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 166.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 84.32 7.06 Favored 'General case' 0 C--N 1.292 -1.928 1 CA-C-N 105.731 -5.213 . . . . 0.0 112.674 146.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.7 t80 -78.47 -20.29 51.25 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.344 0.1 OUTLIER -50.49 -50.29 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 121.055 3.724 . . . . 0.0 121.055 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.12 -60.88 2.15 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.218 -5.446 . . . . 0.0 113.708 158.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 124.292 1.996 . . . . 0.0 111.259 -168.823 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 . . . . . 0 CA--C 1.561 1.379 0 CA-C-O 121.983 0.896 . . . . 0.0 112.85 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -99.74 152.89 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.729 1.252 . . . . 0.0 110.785 164.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.484 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 49.8 t-80 -98.3 -68.21 0.81 Allowed 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.914 170.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 tpt -128.27 101.5 6.27 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.249 1.02 . . . . 0.0 108.485 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 145.76 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 125.022 2.344 . . . . 0.0 110.16 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.343 92.8 m-85 -56.36 -108.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 109.977 -3.283 . . . . 0.0 110.729 134.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -128.88 -121.81 0.23 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 110.361 -3.108 . . . . 0.0 107.932 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -90.91 -48.04 7.24 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.268 61.4 mmt-85 -88.22 -61.72 1.65 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 127.1 3.334 . . . . 0.0 119.973 -164.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.45 -60.29 1.56 Allowed Glycine 0 N--CA 1.479 1.537 0 CA-C-N 119.187 0.903 . . . . 0.0 114.767 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.261 24.3 pttm -127.07 75.15 76.82 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.303 25.3 Cg_endo -68.18 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.327 2.685 . . . . 0.0 109.407 150.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -43.52 -24.43 0.11 Allowed 'General case' 0 N--CA 1.511 2.61 1 N-CA-C 125.718 5.451 . . . . 0.0 125.718 147.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -59.49 1.06 0.51 Allowed Glycine 0 CA--C 1.551 2.339 1 CA-C-N 107.135 -4.575 . . . . 0.0 121.137 157.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -54.78 -49.44 70.91 Favored 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.5 85.28 6.48 Favored 'General case' 0 C--N 1.289 -2.026 1 CA-C-N 105.842 -5.163 . . . . 0.0 112.244 147.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.484 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 4.0 t80 -77.93 -32.13 51.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.313 0.1 OUTLIER -50.25 -50.5 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 121.119 3.748 . . . . 0.0 121.119 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.05 -60.8 3.09 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.041 -5.527 . . . . 0.0 114.29 160.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . 0.277 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 123.003 1.382 . . . . 0.0 111.966 -170.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 pt -142.6 149.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.709 1.242 . . . . 0.0 111.262 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -102.54 -72.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.794 -1.548 . . . . 0.0 109.059 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.52 91.15 2.35 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -87.27 147.52 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 124.981 2.324 . . . . 0.0 109.447 161.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.364 89.4 m-85 -55.64 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 110.103 -3.226 . . . . 0.0 111.366 140.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.1 m -140.12 -118.6 0.12 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 109.993 -3.276 . . . . 0.0 108.366 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.85 -51.98 5.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -90.49 -63.14 1.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 127.069 3.319 . . . . 0.0 119.557 -163.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.22 -54.49 2.99 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.07 75.7 40.15 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.287 17.5 Cg_endo -68.58 -122.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.725 2.284 . . . . 0.0 108.812 144.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -46.56 -24.54 0.55 Allowed 'General case' 0 N--CA 1.51 2.549 1 N-CA-C 125.421 5.341 . . . . 0.0 125.421 148.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -57.37 0.49 0.23 Allowed Glycine 0 CA--C 1.551 2.326 1 CA-C-N 107.53 -4.395 . . . . 0.0 121.167 160.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -50.34 17.7 Favored 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 120.537 3.532 . . . . 0.0 120.537 163.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.59 95.73 9.78 Favored 'General case' 0 C--N 1.294 -1.816 1 CA-C-N 105.598 -5.274 . . . . 0.0 111.748 148.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.12 -18.98 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.312 0.0 OUTLIER -52.33 -49.26 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 120.569 3.544 . . . . 0.0 120.569 175.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.95 -60.54 2.56 Favored 'General case' 0 C--N 1.292 -1.908 1 CA-C-N 105.744 -5.207 . . . . 0.0 113.929 157.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 124.418 2.056 . . . . 0.0 110.917 -165.177 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 pt -141.33 149.44 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 122.611 1.196 . . . . 0.0 110.373 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -98.53 -71.33 0.69 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.7 171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.4 ttp -140.41 91.17 2.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.669 0.788 . . . . 0.0 108.928 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.09 148.79 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 124.475 2.083 . . . . 0.0 109.367 159.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 93.6 m-85 -59.69 -100.24 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 110.998 -2.819 . . . . 0.0 112.141 147.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -95.33 -168.25 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 108.896 -3.775 . . . . 0.0 113.079 -154.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -90.24 -56.04 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.302 0.7 OUTLIER -90.75 -62.19 1.51 Allowed 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 127.307 3.432 . . . . 0.0 118.934 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.95 -39.71 32.35 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.5 80.32 6.03 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 118.733 1.266 . . . . 0.0 111.505 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.302 25.8 Cg_endo -68.61 -119.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.261 2.641 . . . . 0.0 108.966 148.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.415 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 9.2 ptm180 -38.36 -33.83 0.11 Allowed 'General case' 0 N--CA 1.507 2.399 1 N-CA-C 125.221 5.267 . . . . 0.0 125.221 149.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 0.12 0.49 Allowed Glycine 0 CA--C 1.55 2.269 1 CA-C-N 107.309 -4.496 . . . . 0.0 121.379 164.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.59 -50.29 60.46 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.59 91.61 4.1 Favored 'General case' 0 C--N 1.291 -1.966 1 CA-C-N 105.769 -5.196 . . . . 0.0 111.653 149.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -72.83 -21.28 60.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.301 0.0 OUTLIER -52.36 -49.57 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 120.374 3.472 . . . . 0.0 120.374 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.8 -60.66 3.0 Favored 'General case' 0 C--N 1.292 -1.929 1 CA-C-N 105.419 -5.355 . . . . 0.0 114.293 158.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 124.502 2.096 . . . . 0.0 110.474 -165.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -119.82 153.24 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.834 1.302 . . . . 0.0 111.308 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.471 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 53.1 t-80 -96.95 -69.54 0.75 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.818 171.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.5 ttp -130.33 94.61 3.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.898 0.879 . . . . 0.0 108.789 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.72 145.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 124.745 2.212 . . . . 0.0 109.88 159.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.358 86.7 m-85 -57.53 -106.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 110.302 -3.136 . . . . 0.0 110.407 137.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.9 m -128.01 -125.75 0.22 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 110.053 -3.249 . . . . 0.0 107.872 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -91.23 -52.54 4.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.274 83.4 mtt180 -79.91 -61.54 1.96 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 127.14 3.353 . . . . 0.0 120.039 -167.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.68 -56.59 2.75 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -123.24 73.66 49.36 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.3 27.0 Cg_endo -68.97 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.365 2.71 . . . . 0.0 109.546 150.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.01 -27.31 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.725 1 N-CA-C 125.524 5.379 . . . . 0.0 125.524 145.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -60.4 0.71 0.85 Allowed Glycine 0 CA--C 1.553 2.408 1 CA-C-N 107.398 -4.455 . . . . 0.0 121.384 160.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.98 -50.67 60.81 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.43 91.79 6.83 Favored 'General case' 0 C--N 1.29 -1.989 1 CA-C-N 105.687 -5.233 . . . . 0.0 111.994 148.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.3 t80 -83.27 -27.39 29.88 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.351 0.1 OUTLIER -48.64 -50.72 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 121.612 3.93 . . . . 0.0 121.612 -170.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -79.84 -60.89 2.17 Favored 'General case' 0 C--N 1.288 -2.075 1 CA-C-N 105.498 -5.319 . . . . 0.0 113.033 161.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 124.629 2.156 . . . . 0.0 111.915 -165.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 121.207 0.527 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.3 pt -134.65 152.78 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 122.53 1.157 . . . . 0.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -104.94 -72.17 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.026 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 ttt -140.98 80.78 1.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.738 0.815 . . . . 0.0 109.181 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.76 142.04 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-O 124.921 2.296 . . . . 0.0 109.301 165.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.36 89.2 m-85 -81.18 -78.09 0.19 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 110.182 -3.19 . . . . 0.0 114.628 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.1 m -126.07 -144.29 0.31 Allowed 'General case' 0 C--N 1.288 -2.108 1 CA-C-N 105.438 -5.346 . . . . 0.0 110.9 157.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -90.61 -29.16 17.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.333 1.4 mpt_? -89.96 -60.88 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 126.895 3.236 . . . . 0.0 118.96 -172.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.87 -39.73 8.52 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 117.451 1.74 . . . . 0.0 117.451 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.03 69.43 13.87 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 118.732 1.266 . . . . 0.0 113.719 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 15' ' ' GLY 0.289 18.3 Cg_endo -69.92 -122.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.56 1.824 0 C-N-CA 123.017 2.478 . . . . 0.0 108.668 146.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -39.39 -29.0 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.643 1 N-CA-C 125.725 5.454 . . . . 0.0 125.725 147.249 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -61.7 1.07 1.28 Allowed Glycine 0 CA--C 1.547 2.034 1 CA-C-N 106.954 -4.657 . . . . 0.0 121.638 165.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -43.8 -52.15 6.87 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 121.15 3.759 . . . . 0.0 121.15 171.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.29 104.44 15.92 Favored 'General case' 0 C--N 1.293 -1.87 1 CA-C-N 105.397 -5.365 . . . . 0.0 111.141 149.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -83.32 -15.22 50.89 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -55.03 -50.36 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 120.645 3.572 . . . . 0.0 120.645 -175.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -69.13 -60.62 2.23 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.743 -5.208 . . . . 0.0 113.362 156.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 124.494 2.093 . . . . 0.0 110.96 -161.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.43 148.99 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 110.244 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -84.78 -71.72 0.51 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.248 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.67 91.52 1.97 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -79.99 139.78 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 124.798 2.237 . . . . 0.0 109.339 161.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 88.4 m-85 -76.86 -79.63 0.11 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 110.561 -3.018 . . . . 0.0 114.177 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -146.3 -109.25 0.09 Allowed 'General case' 0 C--N 1.291 -1.944 1 CA-C-N 106.122 -5.035 . . . . 0.0 109.857 151.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.56 -60.28 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.309 18.4 mmt180 -69.7 -60.55 2.25 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -168.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.2 -60.34 1.4 Allowed Glycine 0 N--CA 1.479 1.556 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -123.2 67.45 34.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.284 13.9 Cg_endo -68.89 -122.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 122.982 2.455 . . . . 0.0 108.985 145.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 55.1 ptt85 -40.58 -30.51 0.12 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 125.186 5.254 . . . . 0.0 125.186 148.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.18 0.92 0.17 Allowed Glycine 0 CA--C 1.551 2.282 1 CA-C-N 107.233 -4.53 . . . . 0.0 121.535 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -40.36 -51.44 2.8 Favored 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 121.856 4.021 . . . . 0.0 121.856 169.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.96 105.86 16.28 Favored 'General case' 0 C--N 1.292 -1.896 1 CA-C-N 105.731 -5.213 . . . . 0.0 110.671 150.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -81.43 -16.01 53.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.324 0.1 OUTLIER -54.65 -50.21 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 N-CA-C 120.549 3.537 . . . . 0.0 120.549 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.73 -60.6 2.41 Favored 'General case' 0 C--N 1.289 -2.027 1 CA-C-N 105.221 -5.445 . . . . 0.0 113.503 159.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 124.492 2.091 . . . . 0.0 110.683 -167.52 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -94.3 151.99 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.367 1.08 . . . . 0.0 111.377 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.539 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 66.1 t60 -87.75 -72.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.242 165.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.57 100.31 3.58 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -97.77 145.88 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-O 124.967 2.318 . . . . 0.0 109.885 159.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.355 93.8 m-85 -58.47 -105.91 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 109.851 -3.34 . . . . 0.0 111.411 139.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 t -86.6 170.71 11.6 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.83 -3.35 . . . . 0.0 112.95 -162.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -72.02 -49.34 37.76 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.303 9.2 mtp-105 -76.55 -60.69 2.24 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 127.679 3.609 . . . . 0.0 120.677 -174.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.88 -49.33 6.52 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.89 76.65 14.55 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.302 26.7 Cg_endo -67.29 -119.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.4 2.733 . . . . 0.0 109.643 147.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.448 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -43.5 -26.23 0.2 Allowed 'General case' 0 N--CA 1.513 2.69 1 N-CA-C 125.147 5.24 . . . . 0.0 125.147 149.311 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -58.91 1.07 0.37 Allowed Glycine 0 CA--C 1.551 2.301 1 CA-C-N 107.29 -4.504 . . . . 0.0 121.002 157.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.79 -51.13 58.71 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.14 84.81 4.36 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.721 -5.218 . . . . 0.0 112.803 147.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.539 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 6.6 t80 -81.59 -23.59 37.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.304 0.1 OUTLIER -52.39 -50.09 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 173.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -58.74 -60.48 3.77 Favored 'General case' 0 C--N 1.293 -1.849 1 CA-C-N 105.278 -5.419 . . . . 0.0 114.674 158.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 122.713 1.244 . . . . 0.0 110.325 -166.415 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -88.74 148.37 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.697 1.237 . . . . 0.0 111.789 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.471 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 80.3 t60 -94.89 -73.72 0.57 Allowed 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.767 168.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -141.91 87.97 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.833 0.853 . . . . 0.0 109.022 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.7 m -76.66 146.5 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 125.462 2.553 . . . . 0.0 110.961 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.327 74.6 m-85 -53.96 -111.57 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.092 139.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -118.6 -140.06 0.35 Allowed 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 110.87 -2.877 . . . . 0.0 108.886 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.73 -53.73 4.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.73 -1.231 . . . . 0.0 112.982 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.306 56.0 mtt180 -71.76 -60.26 2.32 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 127.298 3.428 . . . . 0.0 120.098 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.73 -60.03 1.55 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.255 60.8 pttt -119.99 72.28 17.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 14' ' ' ARG 0.303 23.9 Cg_endo -69.14 -119.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 123.411 2.74 . . . . 0.0 109.456 148.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -42.99 -25.31 0.09 Allowed 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 125.422 5.341 . . . . 0.0 125.422 147.378 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.58 1.15 1.19 Allowed Glycine 0 CA--C 1.552 2.401 1 CA-C-N 107.306 -4.497 . . . . 0.0 120.959 158.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -52.13 -50.89 60.83 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 166.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 84.32 7.06 Favored 'General case' 0 C--N 1.292 -1.928 1 CA-C-N 105.731 -5.213 . . . . 0.0 112.674 146.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.7 t80 -78.47 -20.29 51.25 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.344 0.1 OUTLIER -50.49 -50.29 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 121.055 3.724 . . . . 0.0 121.055 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.12 -60.88 2.15 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.218 -5.446 . . . . 0.0 113.708 158.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 124.292 1.996 . . . . 0.0 111.259 -168.823 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 122.729 1.252 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.512 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 49.8 t-80 -98.3 -68.21 0.81 Allowed 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.914 170.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 tpt -128.27 101.5 6.27 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.249 1.02 . . . . 0.0 108.485 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 145.76 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 125.022 2.344 . . . . 0.0 110.16 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.343 92.8 m-85 -56.36 -108.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 109.977 -3.283 . . . . 0.0 110.729 134.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -128.88 -121.81 0.23 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 110.361 -3.108 . . . . 0.0 107.932 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -90.91 -48.04 7.24 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.268 61.4 mmt-85 . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 127.1 3.334 . . . . 0.0 119.973 -164.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.261 24.3 pttm -127.07 75.15 76.82 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 25.3 Cg_endo -68.18 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.327 2.685 . . . . 0.0 109.407 150.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -43.52 -24.43 0.11 Allowed 'General case' 0 N--CA 1.511 2.61 1 N-CA-C 125.718 5.451 . . . . 0.0 125.718 147.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 1.06 0.51 Allowed Glycine 0 CA--C 1.551 2.339 1 CA-C-N 107.135 -4.575 . . . . 0.0 121.137 157.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -54.78 -49.44 70.91 Favored 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.5 85.28 6.48 Favored 'General case' 0 C--N 1.289 -2.026 1 CA-C-N 105.842 -5.163 . . . . 0.0 112.244 147.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 4.0 t80 -77.93 -32.13 51.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.313 0.1 OUTLIER -50.25 -50.5 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 121.119 3.748 . . . . 0.0 121.119 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.05 -60.8 3.09 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.041 -5.527 . . . . 0.0 114.29 160.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . 0.277 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 123.003 1.382 . . . . 0.0 111.966 -170.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 122.709 1.242 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.414 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 57.7 t60 -102.54 -72.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.794 -1.548 . . . . 0.0 109.059 169.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.52 91.15 2.35 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -87.27 147.52 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 124.981 2.324 . . . . 0.0 109.447 161.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.364 89.4 m-85 -55.64 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 110.103 -3.226 . . . . 0.0 111.366 140.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.1 m -140.12 -118.6 0.12 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 109.993 -3.276 . . . . 0.0 108.366 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.85 -51.98 5.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 127.069 3.319 . . . . 0.0 119.557 -163.722 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.07 75.7 40.15 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.287 17.5 Cg_endo -68.58 -122.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.725 2.284 . . . . 0.0 108.812 144.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -46.56 -24.54 0.55 Allowed 'General case' 0 N--CA 1.51 2.549 1 N-CA-C 125.421 5.341 . . . . 0.0 125.421 148.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 0.49 0.23 Allowed Glycine 0 CA--C 1.551 2.326 1 CA-C-N 107.53 -4.395 . . . . 0.0 121.167 160.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -50.34 17.7 Favored 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 120.537 3.532 . . . . 0.0 120.537 163.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.59 95.73 9.78 Favored 'General case' 0 C--N 1.294 -1.816 1 CA-C-N 105.598 -5.274 . . . . 0.0 111.748 148.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 2.2 t80 -82.12 -18.98 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 19' ' ' ILE 0.312 0.0 OUTLIER -52.33 -49.26 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 120.569 3.544 . . . . 0.0 120.569 175.822 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.95 -60.54 2.56 Favored 'General case' 0 C--N 1.292 -1.908 1 CA-C-N 105.744 -5.207 . . . . 0.0 113.929 157.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 124.418 2.056 . . . . 0.0 110.917 -165.177 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 pt . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 122.611 1.196 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -98.53 -71.33 0.69 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.7 171.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.4 ttp -140.41 91.17 2.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.669 0.788 . . . . 0.0 108.928 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.09 148.79 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 124.475 2.083 . . . . 0.0 109.367 159.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 93.6 m-85 -59.69 -100.24 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 110.998 -2.819 . . . . 0.0 112.141 147.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -95.33 -168.25 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 108.896 -3.775 . . . . 0.0 113.079 -154.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -90.24 -56.04 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.302 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.197 0 CA-C-O 127.307 3.432 . . . . 0.0 118.934 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.156 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.5 80.32 6.03 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 118.733 1.266 . . . . 0.0 111.505 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 25.8 Cg_endo -68.61 -119.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.261 2.641 . . . . 0.0 108.966 148.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -38.36 -33.83 0.11 Allowed 'General case' 0 N--CA 1.507 2.399 1 N-CA-C 125.221 5.267 . . . . 0.0 125.221 149.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 0.12 0.49 Allowed Glycine 0 CA--C 1.55 2.269 1 CA-C-N 107.309 -4.496 . . . . 0.0 121.379 164.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.59 -50.29 60.46 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.59 91.61 4.1 Favored 'General case' 0 C--N 1.291 -1.966 1 CA-C-N 105.769 -5.196 . . . . 0.0 111.653 149.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -72.83 -21.28 60.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 19' ' ' ILE 0.301 0.0 OUTLIER -52.36 -49.57 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 120.374 3.472 . . . . 0.0 120.374 175.449 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.8 -60.66 3.0 Favored 'General case' 0 C--N 1.292 -1.929 1 CA-C-N 105.419 -5.355 . . . . 0.0 114.293 158.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 124.502 2.096 . . . . 0.0 110.474 -165.763 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.834 1.302 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.474 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 53.1 t-80 -96.95 -69.54 0.75 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.818 171.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.5 ttp -130.33 94.61 3.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.898 0.879 . . . . 0.0 108.789 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.72 145.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 124.745 2.212 . . . . 0.0 109.88 159.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.358 86.7 m-85 -57.53 -106.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 110.302 -3.136 . . . . 0.0 110.407 137.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.9 m -128.01 -125.75 0.22 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 110.053 -3.249 . . . . 0.0 107.872 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -91.23 -52.54 4.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.274 83.4 mtt180 . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 127.14 3.353 . . . . 0.0 120.039 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -123.24 73.66 49.36 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.3 27.0 Cg_endo -68.97 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.365 2.71 . . . . 0.0 109.546 150.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.01 -27.31 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.725 1 N-CA-C 125.524 5.379 . . . . 0.0 125.524 145.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.4 0.71 0.85 Allowed Glycine 0 CA--C 1.553 2.408 1 CA-C-N 107.398 -4.455 . . . . 0.0 121.384 160.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.98 -50.67 60.81 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.43 91.79 6.83 Favored 'General case' 0 C--N 1.29 -1.989 1 CA-C-N 105.687 -5.233 . . . . 0.0 111.994 148.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.474 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.3 t80 -83.27 -27.39 29.88 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 19' ' ' ILE 0.351 0.1 OUTLIER -48.64 -50.72 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 121.612 3.93 . . . . 0.0 121.612 -170.66 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -79.84 -60.89 2.17 Favored 'General case' 0 C--N 1.288 -2.075 1 CA-C-N 105.498 -5.319 . . . . 0.0 113.033 161.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 124.629 2.156 . . . . 0.0 111.915 -165.418 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.3 pt . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 122.53 1.157 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -104.94 -72.17 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.026 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 ttt -140.98 80.78 1.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.738 0.815 . . . . 0.0 109.181 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.76 142.04 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-O 124.921 2.296 . . . . 0.0 109.301 165.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.36 89.2 m-85 -81.18 -78.09 0.19 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 110.182 -3.19 . . . . 0.0 114.628 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.1 m -126.07 -144.29 0.31 Allowed 'General case' 0 C--N 1.288 -2.108 1 CA-C-N 105.438 -5.346 . . . . 0.0 110.9 157.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -90.61 -29.16 17.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.333 1.4 mpt_? . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 126.895 3.236 . . . . 0.0 118.96 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 117.451 1.74 . . . . 0.0 117.451 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.03 69.43 13.87 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 118.732 1.266 . . . . 0.0 113.719 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.289 18.3 Cg_endo -69.92 -122.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.56 1.824 0 C-N-CA 123.017 2.478 . . . . 0.0 108.668 146.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.39 -29.0 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.643 1 N-CA-C 125.725 5.454 . . . . 0.0 125.725 147.249 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.7 1.07 1.28 Allowed Glycine 0 CA--C 1.547 2.034 1 CA-C-N 106.954 -4.657 . . . . 0.0 121.638 165.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -43.8 -52.15 6.87 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 121.15 3.759 . . . . 0.0 121.15 171.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.29 104.44 15.92 Favored 'General case' 0 C--N 1.293 -1.87 1 CA-C-N 105.397 -5.365 . . . . 0.0 111.141 149.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -83.32 -15.22 50.89 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 19' ' ' ILE 0.338 0.1 OUTLIER -55.03 -50.36 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 120.645 3.572 . . . . 0.0 120.645 -175.887 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -69.13 -60.62 2.23 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.743 -5.208 . . . . 0.0 113.362 156.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 124.494 2.093 . . . . 0.0 110.96 -161.913 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -84.78 -71.72 0.51 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.248 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.67 91.52 1.97 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -79.99 139.78 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 124.798 2.237 . . . . 0.0 109.339 161.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 88.4 m-85 -76.86 -79.63 0.11 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 110.561 -3.018 . . . . 0.0 114.177 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -146.3 -109.25 0.09 Allowed 'General case' 0 C--N 1.291 -1.944 1 CA-C-N 106.122 -5.035 . . . . 0.0 109.857 151.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.56 -60.28 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.309 18.4 mmt180 . . . . . 0 N--CA 1.502 2.175 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -168.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -123.2 67.45 34.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.284 13.9 Cg_endo -68.89 -122.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 122.982 2.455 . . . . 0.0 108.985 145.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -40.58 -30.51 0.12 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 125.186 5.254 . . . . 0.0 125.186 148.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.18 0.92 0.17 Allowed Glycine 0 CA--C 1.551 2.282 1 CA-C-N 107.233 -4.53 . . . . 0.0 121.535 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -40.36 -51.44 2.8 Favored 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 121.856 4.021 . . . . 0.0 121.856 169.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.96 105.86 16.28 Favored 'General case' 0 C--N 1.292 -1.896 1 CA-C-N 105.731 -5.213 . . . . 0.0 110.671 150.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -81.43 -16.01 53.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 19' ' ' ILE 0.324 0.1 OUTLIER -54.65 -50.21 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 N-CA-C 120.549 3.537 . . . . 0.0 120.549 -178.791 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.73 -60.6 2.41 Favored 'General case' 0 C--N 1.289 -2.027 1 CA-C-N 105.221 -5.445 . . . . 0.0 113.503 159.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 124.492 2.091 . . . . 0.0 110.683 -167.52 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 122.367 1.08 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 66.1 t60 -87.75 -72.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.242 165.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.57 100.31 3.58 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -97.77 145.88 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-O 124.967 2.318 . . . . 0.0 109.885 159.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.355 93.8 m-85 -58.47 -105.91 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 109.851 -3.34 . . . . 0.0 111.411 139.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 t -86.6 170.71 11.6 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.83 -3.35 . . . . 0.0 112.95 -162.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -72.02 -49.34 37.76 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.303 9.2 mtp-105 . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 127.679 3.609 . . . . 0.0 120.677 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.89 76.65 14.55 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 26.7 Cg_endo -67.29 -119.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.4 2.733 . . . . 0.0 109.643 147.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.5 -26.23 0.2 Allowed 'General case' 0 N--CA 1.513 2.69 1 N-CA-C 125.147 5.24 . . . . 0.0 125.147 149.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.91 1.07 0.37 Allowed Glycine 0 CA--C 1.551 2.301 1 CA-C-N 107.29 -4.504 . . . . 0.0 121.002 157.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.79 -51.13 58.71 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.14 84.81 4.36 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.721 -5.218 . . . . 0.0 112.803 147.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 6.6 t80 -81.59 -23.59 37.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.304 0.1 OUTLIER -52.39 -50.09 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 173.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -58.74 -60.48 3.77 Favored 'General case' 0 C--N 1.293 -1.849 1 CA-C-N 105.278 -5.419 . . . . 0.0 114.674 158.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 122.713 1.244 . . . . 0.0 110.325 -166.415 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 122.697 1.237 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.5 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 80.3 t60 -94.89 -73.72 0.57 Allowed 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.767 168.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -141.91 87.97 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.833 0.853 . . . . 0.0 109.022 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.7 m -76.66 146.5 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 125.462 2.553 . . . . 0.0 110.961 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.327 74.6 m-85 -53.96 -111.57 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.092 139.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -118.6 -140.06 0.35 Allowed 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 110.87 -2.877 . . . . 0.0 108.886 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.73 -53.73 4.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.73 -1.231 . . . . 0.0 112.982 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.306 56.0 mtt180 . . . . . 0 N--CA 1.501 2.12 0 CA-C-O 127.298 3.428 . . . . 0.0 120.098 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.255 60.8 pttt -119.99 72.28 17.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 23.9 Cg_endo -69.14 -119.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 123.411 2.74 . . . . 0.0 109.456 148.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.99 -25.31 0.09 Allowed 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 125.422 5.341 . . . . 0.0 125.422 147.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.58 1.15 1.19 Allowed Glycine 0 CA--C 1.552 2.401 1 CA-C-N 107.306 -4.497 . . . . 0.0 120.959 158.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -52.13 -50.89 60.83 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 166.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 84.32 7.06 Favored 'General case' 0 C--N 1.292 -1.928 1 CA-C-N 105.731 -5.213 . . . . 0.0 112.674 146.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.5 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.7 t80 -78.47 -20.29 51.25 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.344 0.1 OUTLIER -50.49 -50.29 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 121.055 3.724 . . . . 0.0 121.055 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.12 -60.88 2.15 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.218 -5.446 . . . . 0.0 113.708 158.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 124.292 1.996 . . . . 0.0 111.259 -168.823 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 . . . . . 0 CA--C 1.561 1.379 0 CA-C-O 121.983 0.896 . . . . 0.0 112.85 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -99.74 152.89 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.729 1.252 . . . . 0.0 110.785 164.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.512 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 49.8 t-80 -98.3 -68.21 0.81 Allowed 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.914 170.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 tpt -128.27 101.5 6.27 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.249 1.02 . . . . 0.0 108.485 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 145.76 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 125.022 2.344 . . . . 0.0 110.16 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.343 92.8 m-85 -56.36 -108.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 109.977 -3.283 . . . . 0.0 110.729 134.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -128.88 -121.81 0.23 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 110.361 -3.108 . . . . 0.0 107.932 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -90.91 -48.04 7.24 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.268 61.4 mmt-85 -88.22 -61.72 1.65 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 127.1 3.334 . . . . 0.0 119.973 -164.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.45 -60.29 1.56 Allowed Glycine 0 N--CA 1.479 1.537 0 CA-C-N 119.187 0.903 . . . . 0.0 114.767 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.261 24.3 pttm -127.07 75.15 76.82 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 25.3 Cg_endo -68.18 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.327 2.685 . . . . 0.0 109.407 150.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -43.52 -24.43 0.11 Allowed 'General case' 0 N--CA 1.511 2.61 1 N-CA-C 125.718 5.451 . . . . 0.0 125.718 147.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 1.06 0.51 Allowed Glycine 0 CA--C 1.551 2.339 1 CA-C-N 107.135 -4.575 . . . . 0.0 121.137 157.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -54.78 -49.44 70.91 Favored 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.5 85.28 6.48 Favored 'General case' 0 C--N 1.289 -2.026 1 CA-C-N 105.842 -5.163 . . . . 0.0 112.244 147.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 4.0 t80 -77.93 -32.13 51.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.313 0.1 OUTLIER -50.25 -50.5 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 121.119 3.748 . . . . 0.0 121.119 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.05 -60.8 3.09 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.041 -5.527 . . . . 0.0 114.29 160.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . 0.277 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 123.003 1.382 . . . . 0.0 111.966 -170.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 pt -142.6 149.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.709 1.242 . . . . 0.0 111.262 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.414 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 57.7 t60 -102.54 -72.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.794 -1.548 . . . . 0.0 109.059 169.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.52 91.15 2.35 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -87.27 147.52 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 124.981 2.324 . . . . 0.0 109.447 161.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.364 89.4 m-85 -55.64 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 110.103 -3.226 . . . . 0.0 111.366 140.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.1 m -140.12 -118.6 0.12 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 109.993 -3.276 . . . . 0.0 108.366 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.85 -51.98 5.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -90.49 -63.14 1.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 127.069 3.319 . . . . 0.0 119.557 -163.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.22 -54.49 2.99 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.07 75.7 40.15 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.287 17.5 Cg_endo -68.58 -122.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.725 2.284 . . . . 0.0 108.812 144.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -46.56 -24.54 0.55 Allowed 'General case' 0 N--CA 1.51 2.549 1 N-CA-C 125.421 5.341 . . . . 0.0 125.421 148.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 0.49 0.23 Allowed Glycine 0 CA--C 1.551 2.326 1 CA-C-N 107.53 -4.395 . . . . 0.0 121.167 160.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -50.34 17.7 Favored 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 120.537 3.532 . . . . 0.0 120.537 163.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.59 95.73 9.78 Favored 'General case' 0 C--N 1.294 -1.816 1 CA-C-N 105.598 -5.274 . . . . 0.0 111.748 148.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 2.2 t80 -82.12 -18.98 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 19' ' ' ILE 0.312 0.0 OUTLIER -52.33 -49.26 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 120.569 3.544 . . . . 0.0 120.569 175.822 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.95 -60.54 2.56 Favored 'General case' 0 C--N 1.292 -1.908 1 CA-C-N 105.744 -5.207 . . . . 0.0 113.929 157.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 124.418 2.056 . . . . 0.0 110.917 -165.177 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 pt -141.33 149.44 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 122.611 1.196 . . . . 0.0 110.373 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -98.53 -71.33 0.69 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.7 171.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.4 ttp -140.41 91.17 2.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.669 0.788 . . . . 0.0 108.928 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.09 148.79 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 124.475 2.083 . . . . 0.0 109.367 159.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 93.6 m-85 -59.69 -100.24 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 110.998 -2.819 . . . . 0.0 112.141 147.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -95.33 -168.25 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 108.896 -3.775 . . . . 0.0 113.079 -154.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -90.24 -56.04 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.302 0.7 OUTLIER -90.75 -62.19 1.51 Allowed 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 127.307 3.432 . . . . 0.0 118.934 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.95 -39.71 32.35 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.5 80.32 6.03 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 118.733 1.266 . . . . 0.0 111.505 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 25.8 Cg_endo -68.61 -119.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.261 2.641 . . . . 0.0 108.966 148.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -38.36 -33.83 0.11 Allowed 'General case' 0 N--CA 1.507 2.399 1 N-CA-C 125.221 5.267 . . . . 0.0 125.221 149.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 0.12 0.49 Allowed Glycine 0 CA--C 1.55 2.269 1 CA-C-N 107.309 -4.496 . . . . 0.0 121.379 164.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.59 -50.29 60.46 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.59 91.61 4.1 Favored 'General case' 0 C--N 1.291 -1.966 1 CA-C-N 105.769 -5.196 . . . . 0.0 111.653 149.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -72.83 -21.28 60.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 19' ' ' ILE 0.301 0.0 OUTLIER -52.36 -49.57 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 120.374 3.472 . . . . 0.0 120.374 175.449 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.8 -60.66 3.0 Favored 'General case' 0 C--N 1.292 -1.929 1 CA-C-N 105.419 -5.355 . . . . 0.0 114.293 158.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 124.502 2.096 . . . . 0.0 110.474 -165.763 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -119.82 153.24 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.834 1.302 . . . . 0.0 111.308 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 53.1 t-80 -96.95 -69.54 0.75 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.818 171.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.5 ttp -130.33 94.61 3.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.898 0.879 . . . . 0.0 108.789 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.72 145.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 124.745 2.212 . . . . 0.0 109.88 159.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.358 86.7 m-85 -57.53 -106.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 110.302 -3.136 . . . . 0.0 110.407 137.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.9 m -128.01 -125.75 0.22 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 110.053 -3.249 . . . . 0.0 107.872 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -91.23 -52.54 4.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.274 83.4 mtt180 -79.91 -61.54 1.96 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 127.14 3.353 . . . . 0.0 120.039 -167.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.68 -56.59 2.75 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -123.24 73.66 49.36 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.3 27.0 Cg_endo -68.97 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.365 2.71 . . . . 0.0 109.546 150.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.01 -27.31 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.725 1 N-CA-C 125.524 5.379 . . . . 0.0 125.524 145.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.4 0.71 0.85 Allowed Glycine 0 CA--C 1.553 2.408 1 CA-C-N 107.398 -4.455 . . . . 0.0 121.384 160.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.98 -50.67 60.81 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.43 91.79 6.83 Favored 'General case' 0 C--N 1.29 -1.989 1 CA-C-N 105.687 -5.233 . . . . 0.0 111.994 148.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.3 t80 -83.27 -27.39 29.88 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 19' ' ' ILE 0.351 0.1 OUTLIER -48.64 -50.72 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 121.612 3.93 . . . . 0.0 121.612 -170.66 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -79.84 -60.89 2.17 Favored 'General case' 0 C--N 1.288 -2.075 1 CA-C-N 105.498 -5.319 . . . . 0.0 113.033 161.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 124.629 2.156 . . . . 0.0 111.915 -165.418 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 121.207 0.527 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.3 pt -134.65 152.78 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 122.53 1.157 . . . . 0.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -104.94 -72.17 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.026 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 ttt -140.98 80.78 1.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.738 0.815 . . . . 0.0 109.181 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.76 142.04 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-O 124.921 2.296 . . . . 0.0 109.301 165.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.36 89.2 m-85 -81.18 -78.09 0.19 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 110.182 -3.19 . . . . 0.0 114.628 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.1 m -126.07 -144.29 0.31 Allowed 'General case' 0 C--N 1.288 -2.108 1 CA-C-N 105.438 -5.346 . . . . 0.0 110.9 157.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -90.61 -29.16 17.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.333 1.4 mpt_? -89.96 -60.88 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 126.895 3.236 . . . . 0.0 118.96 -172.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.87 -39.73 8.52 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 117.451 1.74 . . . . 0.0 117.451 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.03 69.43 13.87 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 118.732 1.266 . . . . 0.0 113.719 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.289 18.3 Cg_endo -69.92 -122.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.56 1.824 0 C-N-CA 123.017 2.478 . . . . 0.0 108.668 146.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.39 -29.0 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.643 1 N-CA-C 125.725 5.454 . . . . 0.0 125.725 147.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.7 1.07 1.28 Allowed Glycine 0 CA--C 1.547 2.034 1 CA-C-N 106.954 -4.657 . . . . 0.0 121.638 165.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -43.8 -52.15 6.87 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 121.15 3.759 . . . . 0.0 121.15 171.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.29 104.44 15.92 Favored 'General case' 0 C--N 1.293 -1.87 1 CA-C-N 105.397 -5.365 . . . . 0.0 111.141 149.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -83.32 -15.22 50.89 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 19' ' ' ILE 0.338 0.1 OUTLIER -55.03 -50.36 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 120.645 3.572 . . . . 0.0 120.645 -175.887 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -69.13 -60.62 2.23 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.743 -5.208 . . . . 0.0 113.362 156.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 124.494 2.093 . . . . 0.0 110.96 -161.913 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.43 148.99 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 110.244 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -84.78 -71.72 0.51 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.248 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.67 91.52 1.97 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -79.99 139.78 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 124.798 2.237 . . . . 0.0 109.339 161.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 88.4 m-85 -76.86 -79.63 0.11 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 110.561 -3.018 . . . . 0.0 114.177 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -146.3 -109.25 0.09 Allowed 'General case' 0 C--N 1.291 -1.944 1 CA-C-N 106.122 -5.035 . . . . 0.0 109.857 151.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.56 -60.28 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.309 18.4 mmt180 -69.7 -60.55 2.25 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -168.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.2 -60.34 1.4 Allowed Glycine 0 N--CA 1.479 1.556 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -123.2 67.45 34.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.284 13.9 Cg_endo -68.89 -122.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 122.982 2.455 . . . . 0.0 108.985 145.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -40.58 -30.51 0.12 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 125.186 5.254 . . . . 0.0 125.186 148.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.18 0.92 0.17 Allowed Glycine 0 CA--C 1.551 2.282 1 CA-C-N 107.233 -4.53 . . . . 0.0 121.535 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -40.36 -51.44 2.8 Favored 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 121.856 4.021 . . . . 0.0 121.856 169.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.96 105.86 16.28 Favored 'General case' 0 C--N 1.292 -1.896 1 CA-C-N 105.731 -5.213 . . . . 0.0 110.671 150.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -81.43 -16.01 53.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 19' ' ' ILE 0.324 0.1 OUTLIER -54.65 -50.21 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 N-CA-C 120.549 3.537 . . . . 0.0 120.549 -178.791 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.73 -60.6 2.41 Favored 'General case' 0 C--N 1.289 -2.027 1 CA-C-N 105.221 -5.445 . . . . 0.0 113.503 159.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 124.492 2.091 . . . . 0.0 110.683 -167.52 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -94.3 151.99 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.367 1.08 . . . . 0.0 111.377 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 66.1 t60 -87.75 -72.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.242 165.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.57 100.31 3.58 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -97.77 145.88 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-O 124.967 2.318 . . . . 0.0 109.885 159.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.355 93.8 m-85 -58.47 -105.91 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 109.851 -3.34 . . . . 0.0 111.411 139.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 t -86.6 170.71 11.6 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.83 -3.35 . . . . 0.0 112.95 -162.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -72.02 -49.34 37.76 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.303 9.2 mtp-105 -76.55 -60.69 2.24 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 127.679 3.609 . . . . 0.0 120.677 -174.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.88 -49.33 6.52 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.89 76.65 14.55 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 26.7 Cg_endo -67.29 -119.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.4 2.733 . . . . 0.0 109.643 147.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.5 -26.23 0.2 Allowed 'General case' 0 N--CA 1.513 2.69 1 N-CA-C 125.147 5.24 . . . . 0.0 125.147 149.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.91 1.07 0.37 Allowed Glycine 0 CA--C 1.551 2.301 1 CA-C-N 107.29 -4.504 . . . . 0.0 121.002 157.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.79 -51.13 58.71 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.14 84.81 4.36 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.721 -5.218 . . . . 0.0 112.803 147.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 6.6 t80 -81.59 -23.59 37.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.304 0.1 OUTLIER -52.39 -50.09 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 173.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -58.74 -60.48 3.77 Favored 'General case' 0 C--N 1.293 -1.849 1 CA-C-N 105.278 -5.419 . . . . 0.0 114.674 158.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 122.713 1.244 . . . . 0.0 110.325 -166.415 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -88.74 148.37 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.697 1.237 . . . . 0.0 111.789 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.5 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 80.3 t60 -94.89 -73.72 0.57 Allowed 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.767 168.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -141.91 87.97 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.833 0.853 . . . . 0.0 109.022 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.7 m -76.66 146.5 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 125.462 2.553 . . . . 0.0 110.961 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.327 74.6 m-85 -53.96 -111.57 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.092 139.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -118.6 -140.06 0.35 Allowed 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 110.87 -2.877 . . . . 0.0 108.886 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.73 -53.73 4.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.73 -1.231 . . . . 0.0 112.982 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.306 56.0 mtt180 -71.76 -60.26 2.32 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 127.298 3.428 . . . . 0.0 120.098 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.73 -60.03 1.55 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.255 60.8 pttt -119.99 72.28 17.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 23.9 Cg_endo -69.14 -119.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 123.411 2.74 . . . . 0.0 109.456 148.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.99 -25.31 0.09 Allowed 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 125.422 5.341 . . . . 0.0 125.422 147.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.58 1.15 1.19 Allowed Glycine 0 CA--C 1.552 2.401 1 CA-C-N 107.306 -4.497 . . . . 0.0 120.959 158.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -52.13 -50.89 60.83 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 166.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 84.32 7.06 Favored 'General case' 0 C--N 1.292 -1.928 1 CA-C-N 105.731 -5.213 . . . . 0.0 112.674 146.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.5 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.7 t80 -78.47 -20.29 51.25 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.344 0.1 OUTLIER -50.49 -50.29 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 121.055 3.724 . . . . 0.0 121.055 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.12 -60.88 2.15 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.218 -5.446 . . . . 0.0 113.708 158.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 124.292 1.996 . . . . 0.0 111.259 -168.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 122.729 1.252 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.512 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 49.8 t-80 -98.3 -68.21 0.81 Allowed 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.914 170.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 tpt -128.27 101.5 6.27 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.249 1.02 . . . . 0.0 108.485 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 145.76 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 125.022 2.344 . . . . 0.0 110.16 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.343 92.8 m-85 -56.36 -108.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 109.977 -3.283 . . . . 0.0 110.729 134.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -128.88 -121.81 0.23 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 110.361 -3.108 . . . . 0.0 107.932 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -90.91 -48.04 7.24 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.268 61.4 mmt-85 . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 127.1 3.334 . . . . 0.0 119.973 -164.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.261 24.3 pttm -127.07 75.15 76.82 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 25.3 Cg_endo -68.18 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.327 2.685 . . . . 0.0 109.407 150.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -43.52 -24.43 0.11 Allowed 'General case' 0 N--CA 1.511 2.61 1 N-CA-C 125.718 5.451 . . . . 0.0 125.718 147.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 1.06 0.51 Allowed Glycine 0 CA--C 1.551 2.339 1 CA-C-N 107.135 -4.575 . . . . 0.0 121.137 157.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -54.78 -49.44 70.91 Favored 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.5 85.28 6.48 Favored 'General case' 0 C--N 1.289 -2.026 1 CA-C-N 105.842 -5.163 . . . . 0.0 112.244 147.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 4.0 t80 -77.93 -32.13 51.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.313 0.1 OUTLIER -50.25 -50.5 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 121.119 3.748 . . . . 0.0 121.119 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.05 -60.8 3.09 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.041 -5.527 . . . . 0.0 114.29 160.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . 0.277 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 123.003 1.382 . . . . 0.0 111.966 -170.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 122.709 1.242 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.414 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 57.7 t60 -102.54 -72.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.794 -1.548 . . . . 0.0 109.059 169.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.52 91.15 2.35 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -87.27 147.52 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 124.981 2.324 . . . . 0.0 109.447 161.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.364 89.4 m-85 -55.64 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 110.103 -3.226 . . . . 0.0 111.366 140.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.1 m -140.12 -118.6 0.12 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 109.993 -3.276 . . . . 0.0 108.366 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.85 -51.98 5.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 127.069 3.319 . . . . 0.0 119.557 -163.722 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.07 75.7 40.15 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.287 17.5 Cg_endo -68.58 -122.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.725 2.284 . . . . 0.0 108.812 144.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -46.56 -24.54 0.55 Allowed 'General case' 0 N--CA 1.51 2.549 1 N-CA-C 125.421 5.341 . . . . 0.0 125.421 148.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 0.49 0.23 Allowed Glycine 0 CA--C 1.551 2.326 1 CA-C-N 107.53 -4.395 . . . . 0.0 121.167 160.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -50.34 17.7 Favored 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 120.537 3.532 . . . . 0.0 120.537 163.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.59 95.73 9.78 Favored 'General case' 0 C--N 1.294 -1.816 1 CA-C-N 105.598 -5.274 . . . . 0.0 111.748 148.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 2.2 t80 -82.12 -18.98 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 19' ' ' ILE 0.312 0.0 OUTLIER -52.33 -49.26 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 120.569 3.544 . . . . 0.0 120.569 175.822 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.95 -60.54 2.56 Favored 'General case' 0 C--N 1.292 -1.908 1 CA-C-N 105.744 -5.207 . . . . 0.0 113.929 157.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 124.418 2.056 . . . . 0.0 110.917 -165.177 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 pt . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 122.611 1.196 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -98.53 -71.33 0.69 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.7 171.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.4 ttp -140.41 91.17 2.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.669 0.788 . . . . 0.0 108.928 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.09 148.79 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 124.475 2.083 . . . . 0.0 109.367 159.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 93.6 m-85 -59.69 -100.24 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 110.998 -2.819 . . . . 0.0 112.141 147.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -95.33 -168.25 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 108.896 -3.775 . . . . 0.0 113.079 -154.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -90.24 -56.04 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.302 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.197 0 CA-C-O 127.307 3.432 . . . . 0.0 118.934 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.156 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.5 80.32 6.03 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 118.733 1.266 . . . . 0.0 111.505 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 25.8 Cg_endo -68.61 -119.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.261 2.641 . . . . 0.0 108.966 148.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -38.36 -33.83 0.11 Allowed 'General case' 0 N--CA 1.507 2.399 1 N-CA-C 125.221 5.267 . . . . 0.0 125.221 149.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 0.12 0.49 Allowed Glycine 0 CA--C 1.55 2.269 1 CA-C-N 107.309 -4.496 . . . . 0.0 121.379 164.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.59 -50.29 60.46 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.59 91.61 4.1 Favored 'General case' 0 C--N 1.291 -1.966 1 CA-C-N 105.769 -5.196 . . . . 0.0 111.653 149.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -72.83 -21.28 60.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 19' ' ' ILE 0.301 0.0 OUTLIER -52.36 -49.57 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 120.374 3.472 . . . . 0.0 120.374 175.449 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.8 -60.66 3.0 Favored 'General case' 0 C--N 1.292 -1.929 1 CA-C-N 105.419 -5.355 . . . . 0.0 114.293 158.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 124.502 2.096 . . . . 0.0 110.474 -165.763 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.834 1.302 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.474 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 53.1 t-80 -96.95 -69.54 0.75 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.818 171.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.5 ttp -130.33 94.61 3.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.898 0.879 . . . . 0.0 108.789 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.72 145.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 124.745 2.212 . . . . 0.0 109.88 159.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.358 86.7 m-85 -57.53 -106.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 110.302 -3.136 . . . . 0.0 110.407 137.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.9 m -128.01 -125.75 0.22 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 110.053 -3.249 . . . . 0.0 107.872 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -91.23 -52.54 4.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.274 83.4 mtt180 . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 127.14 3.353 . . . . 0.0 120.039 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -123.24 73.66 49.36 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.3 27.0 Cg_endo -68.97 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.365 2.71 . . . . 0.0 109.546 150.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.01 -27.31 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.725 1 N-CA-C 125.524 5.379 . . . . 0.0 125.524 145.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.4 0.71 0.85 Allowed Glycine 0 CA--C 1.553 2.408 1 CA-C-N 107.398 -4.455 . . . . 0.0 121.384 160.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.98 -50.67 60.81 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.43 91.79 6.83 Favored 'General case' 0 C--N 1.29 -1.989 1 CA-C-N 105.687 -5.233 . . . . 0.0 111.994 148.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.474 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.3 t80 -83.27 -27.39 29.88 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 19' ' ' ILE 0.351 0.1 OUTLIER -48.64 -50.72 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 121.612 3.93 . . . . 0.0 121.612 -170.66 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -79.84 -60.89 2.17 Favored 'General case' 0 C--N 1.288 -2.075 1 CA-C-N 105.498 -5.319 . . . . 0.0 113.033 161.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 124.629 2.156 . . . . 0.0 111.915 -165.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.3 pt . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 122.53 1.157 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -104.94 -72.17 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.026 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 ttt -140.98 80.78 1.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.738 0.815 . . . . 0.0 109.181 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.76 142.04 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-O 124.921 2.296 . . . . 0.0 109.301 165.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.36 89.2 m-85 -81.18 -78.09 0.19 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 110.182 -3.19 . . . . 0.0 114.628 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.1 m -126.07 -144.29 0.31 Allowed 'General case' 0 C--N 1.288 -2.108 1 CA-C-N 105.438 -5.346 . . . . 0.0 110.9 157.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -90.61 -29.16 17.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.333 1.4 mpt_? . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 126.895 3.236 . . . . 0.0 118.96 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 117.451 1.74 . . . . 0.0 117.451 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.03 69.43 13.87 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 118.732 1.266 . . . . 0.0 113.719 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.289 18.3 Cg_endo -69.92 -122.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.56 1.824 0 C-N-CA 123.017 2.478 . . . . 0.0 108.668 146.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.39 -29.0 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.643 1 N-CA-C 125.725 5.454 . . . . 0.0 125.725 147.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.7 1.07 1.28 Allowed Glycine 0 CA--C 1.547 2.034 1 CA-C-N 106.954 -4.657 . . . . 0.0 121.638 165.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -43.8 -52.15 6.87 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 121.15 3.759 . . . . 0.0 121.15 171.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.29 104.44 15.92 Favored 'General case' 0 C--N 1.293 -1.87 1 CA-C-N 105.397 -5.365 . . . . 0.0 111.141 149.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -83.32 -15.22 50.89 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 19' ' ' ILE 0.338 0.1 OUTLIER -55.03 -50.36 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 120.645 3.572 . . . . 0.0 120.645 -175.887 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -69.13 -60.62 2.23 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.743 -5.208 . . . . 0.0 113.362 156.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 124.494 2.093 . . . . 0.0 110.96 -161.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -84.78 -71.72 0.51 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.248 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.67 91.52 1.97 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -79.99 139.78 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 124.798 2.237 . . . . 0.0 109.339 161.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 88.4 m-85 -76.86 -79.63 0.11 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 110.561 -3.018 . . . . 0.0 114.177 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -146.3 -109.25 0.09 Allowed 'General case' 0 C--N 1.291 -1.944 1 CA-C-N 106.122 -5.035 . . . . 0.0 109.857 151.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.56 -60.28 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.309 18.4 mmt180 . . . . . 0 N--CA 1.502 2.175 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -168.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -123.2 67.45 34.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.284 13.9 Cg_endo -68.89 -122.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 122.982 2.455 . . . . 0.0 108.985 145.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -40.58 -30.51 0.12 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 125.186 5.254 . . . . 0.0 125.186 148.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.18 0.92 0.17 Allowed Glycine 0 CA--C 1.551 2.282 1 CA-C-N 107.233 -4.53 . . . . 0.0 121.535 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -40.36 -51.44 2.8 Favored 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 121.856 4.021 . . . . 0.0 121.856 169.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.96 105.86 16.28 Favored 'General case' 0 C--N 1.292 -1.896 1 CA-C-N 105.731 -5.213 . . . . 0.0 110.671 150.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -81.43 -16.01 53.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 19' ' ' ILE 0.324 0.1 OUTLIER -54.65 -50.21 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 N-CA-C 120.549 3.537 . . . . 0.0 120.549 -178.791 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.73 -60.6 2.41 Favored 'General case' 0 C--N 1.289 -2.027 1 CA-C-N 105.221 -5.445 . . . . 0.0 113.503 159.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 124.492 2.091 . . . . 0.0 110.683 -167.52 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 122.367 1.08 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 66.1 t60 -87.75 -72.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.242 165.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.57 100.31 3.58 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -97.77 145.88 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-O 124.967 2.318 . . . . 0.0 109.885 159.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.355 93.8 m-85 -58.47 -105.91 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 109.851 -3.34 . . . . 0.0 111.411 139.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 t -86.6 170.71 11.6 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.83 -3.35 . . . . 0.0 112.95 -162.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -72.02 -49.34 37.76 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.303 9.2 mtp-105 . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 127.679 3.609 . . . . 0.0 120.677 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.89 76.65 14.55 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 26.7 Cg_endo -67.29 -119.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.4 2.733 . . . . 0.0 109.643 147.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.5 -26.23 0.2 Allowed 'General case' 0 N--CA 1.513 2.69 1 N-CA-C 125.147 5.24 . . . . 0.0 125.147 149.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.91 1.07 0.37 Allowed Glycine 0 CA--C 1.551 2.301 1 CA-C-N 107.29 -4.504 . . . . 0.0 121.002 157.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.79 -51.13 58.71 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.14 84.81 4.36 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.721 -5.218 . . . . 0.0 112.803 147.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 6.6 t80 -81.59 -23.59 37.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.304 0.1 OUTLIER -52.39 -50.09 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 173.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -58.74 -60.48 3.77 Favored 'General case' 0 C--N 1.293 -1.849 1 CA-C-N 105.278 -5.419 . . . . 0.0 114.674 158.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 122.713 1.244 . . . . 0.0 110.325 -166.415 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 122.697 1.237 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.5 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 80.3 t60 -94.89 -73.72 0.57 Allowed 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.767 168.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -141.91 87.97 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.833 0.853 . . . . 0.0 109.022 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.7 m -76.66 146.5 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 125.462 2.553 . . . . 0.0 110.961 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.327 74.6 m-85 -53.96 -111.57 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.092 139.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -118.6 -140.06 0.35 Allowed 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 110.87 -2.877 . . . . 0.0 108.886 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.73 -53.73 4.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.73 -1.231 . . . . 0.0 112.982 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.306 56.0 mtt180 . . . . . 0 N--CA 1.501 2.12 0 CA-C-O 127.298 3.428 . . . . 0.0 120.098 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.255 60.8 pttt -119.99 72.28 17.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 23.9 Cg_endo -69.14 -119.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 123.411 2.74 . . . . 0.0 109.456 148.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.99 -25.31 0.09 Allowed 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 125.422 5.341 . . . . 0.0 125.422 147.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.58 1.15 1.19 Allowed Glycine 0 CA--C 1.552 2.401 1 CA-C-N 107.306 -4.497 . . . . 0.0 120.959 158.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -52.13 -50.89 60.83 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 166.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 84.32 7.06 Favored 'General case' 0 C--N 1.292 -1.928 1 CA-C-N 105.731 -5.213 . . . . 0.0 112.674 146.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.5 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.7 t80 -78.47 -20.29 51.25 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.344 0.1 OUTLIER -50.49 -50.29 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 121.055 3.724 . . . . 0.0 121.055 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.12 -60.88 2.15 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.218 -5.446 . . . . 0.0 113.708 158.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 124.292 1.996 . . . . 0.0 111.259 -168.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 . . . . . 0 CA--C 1.561 1.379 0 CA-C-O 121.983 0.896 . . . . 0.0 112.85 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -99.74 152.89 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.729 1.252 . . . . 0.0 110.785 164.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.512 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 49.8 t-80 -98.3 -68.21 0.81 Allowed 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.914 170.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 tpt -128.27 101.5 6.27 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.249 1.02 . . . . 0.0 108.485 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 145.76 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 125.022 2.344 . . . . 0.0 110.16 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.343 92.8 m-85 -56.36 -108.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 109.977 -3.283 . . . . 0.0 110.729 134.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -128.88 -121.81 0.23 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 110.361 -3.108 . . . . 0.0 107.932 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -90.91 -48.04 7.24 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.268 61.4 mmt-85 -88.22 -61.72 1.65 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 127.1 3.334 . . . . 0.0 119.973 -164.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.45 -60.29 1.56 Allowed Glycine 0 N--CA 1.479 1.537 0 CA-C-N 119.187 0.903 . . . . 0.0 114.767 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.261 24.3 pttm -127.07 75.15 76.82 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 25.3 Cg_endo -68.18 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.327 2.685 . . . . 0.0 109.407 150.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -43.52 -24.43 0.11 Allowed 'General case' 0 N--CA 1.511 2.61 1 N-CA-C 125.718 5.451 . . . . 0.0 125.718 147.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 1.06 0.51 Allowed Glycine 0 CA--C 1.551 2.339 1 CA-C-N 107.135 -4.575 . . . . 0.0 121.137 157.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -54.78 -49.44 70.91 Favored 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.5 85.28 6.48 Favored 'General case' 0 C--N 1.289 -2.026 1 CA-C-N 105.842 -5.163 . . . . 0.0 112.244 147.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 4.0 t80 -77.93 -32.13 51.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.313 0.1 OUTLIER -50.25 -50.5 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 121.119 3.748 . . . . 0.0 121.119 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.05 -60.8 3.09 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.041 -5.527 . . . . 0.0 114.29 160.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . 0.277 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 123.003 1.382 . . . . 0.0 111.966 -170.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 pt -142.6 149.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.709 1.242 . . . . 0.0 111.262 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.414 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 57.7 t60 -102.54 -72.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.794 -1.548 . . . . 0.0 109.059 169.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.52 91.15 2.35 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -87.27 147.52 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 124.981 2.324 . . . . 0.0 109.447 161.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.364 89.4 m-85 -55.64 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 110.103 -3.226 . . . . 0.0 111.366 140.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.1 m -140.12 -118.6 0.12 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 109.993 -3.276 . . . . 0.0 108.366 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.85 -51.98 5.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -90.49 -63.14 1.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 127.069 3.319 . . . . 0.0 119.557 -163.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.22 -54.49 2.99 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.07 75.7 40.15 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.287 17.5 Cg_endo -68.58 -122.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.725 2.284 . . . . 0.0 108.812 144.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -46.56 -24.54 0.55 Allowed 'General case' 0 N--CA 1.51 2.549 1 N-CA-C 125.421 5.341 . . . . 0.0 125.421 148.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 0.49 0.23 Allowed Glycine 0 CA--C 1.551 2.326 1 CA-C-N 107.53 -4.395 . . . . 0.0 121.167 160.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -50.34 17.7 Favored 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 120.537 3.532 . . . . 0.0 120.537 163.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.59 95.73 9.78 Favored 'General case' 0 C--N 1.294 -1.816 1 CA-C-N 105.598 -5.274 . . . . 0.0 111.748 148.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 2.2 t80 -82.12 -18.98 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 19' ' ' ILE 0.312 0.0 OUTLIER -52.33 -49.26 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 120.569 3.544 . . . . 0.0 120.569 175.822 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.95 -60.54 2.56 Favored 'General case' 0 C--N 1.292 -1.908 1 CA-C-N 105.744 -5.207 . . . . 0.0 113.929 157.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 124.418 2.056 . . . . 0.0 110.917 -165.177 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 pt -141.33 149.44 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 122.611 1.196 . . . . 0.0 110.373 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -98.53 -71.33 0.69 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.7 171.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.4 ttp -140.41 91.17 2.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.669 0.788 . . . . 0.0 108.928 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.09 148.79 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-O 124.475 2.083 . . . . 0.0 109.367 159.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 93.6 m-85 -59.69 -100.24 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 110.998 -2.819 . . . . 0.0 112.141 147.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -95.33 -168.25 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 108.896 -3.775 . . . . 0.0 113.079 -154.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -90.24 -56.04 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.302 0.7 OUTLIER -90.75 -62.19 1.51 Allowed 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 127.307 3.432 . . . . 0.0 118.934 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.95 -39.71 32.35 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.5 80.32 6.03 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 118.733 1.266 . . . . 0.0 111.505 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 25.8 Cg_endo -68.61 -119.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.261 2.641 . . . . 0.0 108.966 148.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -38.36 -33.83 0.11 Allowed 'General case' 0 N--CA 1.507 2.399 1 N-CA-C 125.221 5.267 . . . . 0.0 125.221 149.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 0.12 0.49 Allowed Glycine 0 CA--C 1.55 2.269 1 CA-C-N 107.309 -4.496 . . . . 0.0 121.379 164.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.59 -50.29 60.46 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.59 91.61 4.1 Favored 'General case' 0 C--N 1.291 -1.966 1 CA-C-N 105.769 -5.196 . . . . 0.0 111.653 149.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -72.83 -21.28 60.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 19' ' ' ILE 0.301 0.0 OUTLIER -52.36 -49.57 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 120.374 3.472 . . . . 0.0 120.374 175.449 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.8 -60.66 3.0 Favored 'General case' 0 C--N 1.292 -1.929 1 CA-C-N 105.419 -5.355 . . . . 0.0 114.293 158.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 124.502 2.096 . . . . 0.0 110.474 -165.763 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -119.82 153.24 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.834 1.302 . . . . 0.0 111.308 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 53.1 t-80 -96.95 -69.54 0.75 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.818 171.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.5 ttp -130.33 94.61 3.71 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.898 0.879 . . . . 0.0 108.789 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.72 145.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 124.745 2.212 . . . . 0.0 109.88 159.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.358 86.7 m-85 -57.53 -106.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 110.302 -3.136 . . . . 0.0 110.407 137.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.9 m -128.01 -125.75 0.22 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 110.053 -3.249 . . . . 0.0 107.872 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -91.23 -52.54 4.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.274 83.4 mtt180 -79.91 -61.54 1.96 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 127.14 3.353 . . . . 0.0 120.039 -167.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.68 -56.59 2.75 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -123.24 73.66 49.36 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.3 27.0 Cg_endo -68.97 -119.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.365 2.71 . . . . 0.0 109.546 150.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.01 -27.31 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.725 1 N-CA-C 125.524 5.379 . . . . 0.0 125.524 145.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.4 0.71 0.85 Allowed Glycine 0 CA--C 1.553 2.408 1 CA-C-N 107.398 -4.455 . . . . 0.0 121.384 160.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.98 -50.67 60.81 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.43 91.79 6.83 Favored 'General case' 0 C--N 1.29 -1.989 1 CA-C-N 105.687 -5.233 . . . . 0.0 111.994 148.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.3 t80 -83.27 -27.39 29.88 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 19' ' ' ILE 0.351 0.1 OUTLIER -48.64 -50.72 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 121.612 3.93 . . . . 0.0 121.612 -170.66 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -79.84 -60.89 2.17 Favored 'General case' 0 C--N 1.288 -2.075 1 CA-C-N 105.498 -5.319 . . . . 0.0 113.033 161.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 124.629 2.156 . . . . 0.0 111.915 -165.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 121.207 0.527 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.3 pt -134.65 152.78 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 122.53 1.157 . . . . 0.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -104.94 -72.17 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.026 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 ttt -140.98 80.78 1.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.738 0.815 . . . . 0.0 109.181 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.76 142.04 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-O 124.921 2.296 . . . . 0.0 109.301 165.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.36 89.2 m-85 -81.18 -78.09 0.19 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 110.182 -3.19 . . . . 0.0 114.628 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.1 m -126.07 -144.29 0.31 Allowed 'General case' 0 C--N 1.288 -2.108 1 CA-C-N 105.438 -5.346 . . . . 0.0 110.9 157.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -90.61 -29.16 17.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.333 1.4 mpt_? -89.96 -60.88 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 126.895 3.236 . . . . 0.0 118.96 -172.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.87 -39.73 8.52 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 117.451 1.74 . . . . 0.0 117.451 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.03 69.43 13.87 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 118.732 1.266 . . . . 0.0 113.719 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.289 18.3 Cg_endo -69.92 -122.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.56 1.824 0 C-N-CA 123.017 2.478 . . . . 0.0 108.668 146.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.39 -29.0 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.643 1 N-CA-C 125.725 5.454 . . . . 0.0 125.725 147.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.7 1.07 1.28 Allowed Glycine 0 CA--C 1.547 2.034 1 CA-C-N 106.954 -4.657 . . . . 0.0 121.638 165.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -43.8 -52.15 6.87 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 121.15 3.759 . . . . 0.0 121.15 171.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.29 104.44 15.92 Favored 'General case' 0 C--N 1.293 -1.87 1 CA-C-N 105.397 -5.365 . . . . 0.0 111.141 149.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -83.32 -15.22 50.89 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 19' ' ' ILE 0.338 0.1 OUTLIER -55.03 -50.36 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 120.645 3.572 . . . . 0.0 120.645 -175.887 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -69.13 -60.62 2.23 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.743 -5.208 . . . . 0.0 113.362 156.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 124.494 2.093 . . . . 0.0 110.96 -161.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.43 148.99 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 110.244 173.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -84.78 -71.72 0.51 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.248 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.67 91.52 1.97 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -79.99 139.78 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 124.798 2.237 . . . . 0.0 109.339 161.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.369 88.4 m-85 -76.86 -79.63 0.11 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 110.561 -3.018 . . . . 0.0 114.177 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -146.3 -109.25 0.09 Allowed 'General case' 0 C--N 1.291 -1.944 1 CA-C-N 106.122 -5.035 . . . . 0.0 109.857 151.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.56 -60.28 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.309 18.4 mmt180 -69.7 -60.55 2.25 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -168.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.2 -60.34 1.4 Allowed Glycine 0 N--CA 1.479 1.556 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -123.2 67.45 34.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.284 13.9 Cg_endo -68.89 -122.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 122.982 2.455 . . . . 0.0 108.985 145.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -40.58 -30.51 0.12 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 125.186 5.254 . . . . 0.0 125.186 148.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.18 0.92 0.17 Allowed Glycine 0 CA--C 1.551 2.282 1 CA-C-N 107.233 -4.53 . . . . 0.0 121.535 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -40.36 -51.44 2.8 Favored 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 121.856 4.021 . . . . 0.0 121.856 169.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.96 105.86 16.28 Favored 'General case' 0 C--N 1.292 -1.896 1 CA-C-N 105.731 -5.213 . . . . 0.0 110.671 150.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -81.43 -16.01 53.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 19' ' ' ILE 0.324 0.1 OUTLIER -54.65 -50.21 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 N-CA-C 120.549 3.537 . . . . 0.0 120.549 -178.791 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.73 -60.6 2.41 Favored 'General case' 0 C--N 1.289 -2.027 1 CA-C-N 105.221 -5.445 . . . . 0.0 113.503 159.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 124.492 2.091 . . . . 0.0 110.683 -167.52 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -94.3 151.99 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.367 1.08 . . . . 0.0 111.377 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 66.1 t60 -87.75 -72.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.242 165.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.57 100.31 3.58 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -97.77 145.88 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-O 124.967 2.318 . . . . 0.0 109.885 159.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.355 93.8 m-85 -58.47 -105.91 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 109.851 -3.34 . . . . 0.0 111.411 139.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 t -86.6 170.71 11.6 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.83 -3.35 . . . . 0.0 112.95 -162.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -72.02 -49.34 37.76 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.303 9.2 mtp-105 -76.55 -60.69 2.24 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 127.679 3.609 . . . . 0.0 120.677 -174.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.88 -49.33 6.52 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.89 76.65 14.55 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.302 26.7 Cg_endo -67.29 -119.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.4 2.733 . . . . 0.0 109.643 147.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.5 -26.23 0.2 Allowed 'General case' 0 N--CA 1.513 2.69 1 N-CA-C 125.147 5.24 . . . . 0.0 125.147 149.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.91 1.07 0.37 Allowed Glycine 0 CA--C 1.551 2.301 1 CA-C-N 107.29 -4.504 . . . . 0.0 121.002 157.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -51.79 -51.13 58.71 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.14 84.81 4.36 Favored 'General case' 0 C--N 1.291 -1.95 1 CA-C-N 105.721 -5.218 . . . . 0.0 112.803 147.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 6.6 t80 -81.59 -23.59 37.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.304 0.1 OUTLIER -52.39 -50.09 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 173.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -58.74 -60.48 3.77 Favored 'General case' 0 C--N 1.293 -1.849 1 CA-C-N 105.278 -5.419 . . . . 0.0 114.674 158.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 122.713 1.244 . . . . 0.0 110.325 -166.415 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -88.74 148.37 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.697 1.237 . . . . 0.0 111.789 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.5 ' H ' ' HB3' ' A' ' 18' ' ' PHE . 80.3 t60 -94.89 -73.72 0.57 Allowed 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.767 168.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -141.91 87.97 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.833 0.853 . . . . 0.0 109.022 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.7 m -76.66 146.5 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 125.462 2.553 . . . . 0.0 110.961 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.327 74.6 m-85 -53.96 -111.57 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.092 139.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -118.6 -140.06 0.35 Allowed 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 110.87 -2.877 . . . . 0.0 108.886 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.73 -53.73 4.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.73 -1.231 . . . . 0.0 112.982 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.306 56.0 mtt180 -71.76 -60.26 2.32 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 127.298 3.428 . . . . 0.0 120.098 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.73 -60.03 1.55 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.255 60.8 pttt -119.99 72.28 17.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . 0.303 23.9 Cg_endo -69.14 -119.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 123.411 2.74 . . . . 0.0 109.456 148.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.99 -25.31 0.09 Allowed 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 125.422 5.341 . . . . 0.0 125.422 147.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.58 1.15 1.19 Allowed Glycine 0 CA--C 1.552 2.401 1 CA-C-N 107.306 -4.497 . . . . 0.0 120.959 158.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -52.13 -50.89 60.83 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 166.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 84.32 7.06 Favored 'General case' 0 C--N 1.292 -1.928 1 CA-C-N 105.731 -5.213 . . . . 0.0 112.674 146.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.5 ' HB3' ' H ' ' A' ' 3' ' ' HIS . 3.7 t80 -78.47 -20.29 51.25 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.344 0.1 OUTLIER -50.49 -50.29 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 121.055 3.724 . . . . 0.0 121.055 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.12 -60.88 2.15 Favored 'General case' 0 C--N 1.29 -1.988 1 CA-C-N 105.218 -5.446 . . . . 0.0 113.708 158.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 124.292 1.996 . . . . 0.0 111.259 -168.823 . . . . . . . . 0 0 . 1 stop_ save_